Estados Unidos · Plataformas y datos · MarketBeat

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Publicado por MarketBeat · Estados Unidos hace 1 h

Insmed, Inc. (NASDAQ:INSM - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-five analysts that are presently covering the company,…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

También te puede interesar

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Compartir

También te puede interesar

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.